November 17, 2009 bioMérieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment
November 12, 2009 New A(H1N1) Strain Added to bioMérieux’s Molecular Diagnostic Test NucliSENS EasyQ® Influenza A/B
November 6, 2009 bioMérieux Launches a Molecular Diagnostic MRSA Test on its EasyQ® Automated Platform
November 3, 2009 Alain Pluquet's appointment
October 28, 2009 chromIDTM MRSA Launched in U.S. - bioMérieux Adds Methicillin-resistant Staphylococcus aureus (MRSA) Screening Tool to its Arsenal
October 20, 2009 bioMérieux - Business Review for the nine months ended September 30, 2009
“We belong to a community" is one of bioMérieux's guiding principles. At each of our sites and subsidiaries throughout the world, our employees are joining forces to achieve bioMérieux's environmental goals.
bioMérieux Pandemic Preparedness bioMérieux is contributing its expertise in infectious disease diagnostics to the global effort to address the Influenza A/H1N1 pandemic.
Delivering the future with Full Microbiology Lab Automation™ bioMérieux is leading the way in the microbiology lab to streamline workflow, accelerate time to results and boost efficiency.